AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicin.
Rosen DB, Harrington KH, Cordeiro JA, Leung LY, Putta S, Lacayo N, Laszlo GS, Gudgeon CJ, Hogge DE, Hawtin RE, Cesano A, Walter RB.
Rosen DB, et al. Among authors: walter rb.
PLoS One. 2013;8(1):e53518. doi: 10.1371/journal.pone.0053518. Epub 2013 Jan 8.
PLoS One. 2013.
PMID: 23320091
Free PMC article.